🇺🇸 FDA
Patent

US 12397034

Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesis and inhibiting senescence of brain neurons

granted A61KA61K31/05A61K31/11

Quick answer

US patent 12397034 (Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesis and inhibiting senescence of brain neurons) held by China Medical University expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/05, A61K31/11, A61K31/7034, A61K31/7076